NO20002686D0 - Forbedring av Peyronies sykdom - Google Patents

Forbedring av Peyronies sykdom

Info

Publication number
NO20002686D0
NO20002686D0 NO20002686A NO20002686A NO20002686D0 NO 20002686 D0 NO20002686 D0 NO 20002686D0 NO 20002686 A NO20002686 A NO 20002686A NO 20002686 A NO20002686 A NO 20002686A NO 20002686 D0 NO20002686 D0 NO 20002686D0
Authority
NO
Norway
Prior art keywords
peyronie
disease
improvement
Prior art date
Application number
NO20002686A
Other languages
English (en)
Other versions
NO333945B1 (no
NO20002686L (no
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of NO20002686D0 publication Critical patent/NO20002686D0/no
Publication of NO20002686L publication Critical patent/NO20002686L/no
Publication of NO333945B1 publication Critical patent/NO333945B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002686A 1999-06-03 2000-05-25 Anvendelse av kollagenase til fremstilling av et legemiddel for behandling av et individ som lider av Peyronies sykdom. NO333945B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/325,224 US6022539A (en) 1999-06-03 1999-06-03 Amelioration of peyronie's disease

Publications (3)

Publication Number Publication Date
NO20002686D0 true NO20002686D0 (no) 2000-05-25
NO20002686L NO20002686L (no) 2000-12-04
NO333945B1 NO333945B1 (no) 2013-10-28

Family

ID=23266961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002686A NO333945B1 (no) 1999-06-03 2000-05-25 Anvendelse av kollagenase til fremstilling av et legemiddel for behandling av et individ som lider av Peyronies sykdom.

Country Status (9)

Country Link
US (1) US6022539A (no)
AU (1) AU3532900A (no)
CA (1) CA2308842C (no)
DE (1) DE10027521A1 (no)
DK (1) DK177177B1 (no)
FR (1) FR2794369B1 (no)
GB (1) GB2352173B (no)
NO (1) NO333945B1 (no)
SE (1) SE0001914L (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2197018B1 (es) * 2002-06-06 2005-10-01 Especialidades Farmaceuticas Centrum Sa Nuevo uso terapeutico de los extractos de polypodium.
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
JP4967081B2 (ja) * 2005-01-21 2012-07-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク 癒着性関節包炎の処置方法
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US20080233614A1 (en) * 2007-02-13 2008-09-25 Cranenburgh Rocky M Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
WO2010022016A1 (en) * 2008-08-19 2010-02-25 Auxilium International Holdings, Inc. Method of treating peyronie's disease
JP5649589B2 (ja) * 2009-03-06 2015-01-07 ハロザイム インコーポレイテッド マトリックスメタロプロテアーゼ１の温度感受性突然変異体およびその使用
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
US9180172B2 (en) * 2010-12-15 2015-11-10 Ams Research Corporation Treatment of Peyronies disease
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
CN103687607B (zh) 2011-07-20 2018-01-30 麦迪伍德有限公司 用于治疗结缔组织疾患的来自菠萝蛋白酶的蛋白水解提取物
DK2802652T3 (da) 2012-01-12 2019-07-15 Endo Global Ventures Clostridium histolyticum enzym
US10751374B2 (en) * 2012-01-30 2020-08-25 Michael P. Zahalsky Methods and compositions for treatment of penile defects
US20180028575A1 (en) 2012-01-30 2018-02-01 Michael Zahalsky Methods and compositions for treatment of penile defects
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
EP3034091A1 (en) 2013-03-15 2016-06-22 BioSpecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
JP7558654B2 (ja) 2017-03-01 2024-10-01 エンド ベンチャーズ アンリミテッド カンパニー セルライトを評価及び処置するための装置及び方法
KR20240001279A (ko) 2017-03-28 2024-01-03 엔도 벤쳐즈 리미티드 개선된 콜라게나제 생성 방법
EP4045078A1 (en) 2019-10-15 2022-08-24 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
AU5045690A (en) * 1989-01-27 1990-08-24 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease

Also Published As

Publication number Publication date
DE10027521A1 (de) 2000-12-07
AU3532900A (en) 2000-12-07
SE0001914L (sv) 2000-12-04
FR2794369A1 (fr) 2000-12-08
NO333945B1 (no) 2013-10-28
GB2352173A (en) 2001-01-24
FR2794369B1 (fr) 2003-11-21
GB0011969D0 (en) 2000-07-05
CA2308842C (en) 2013-02-12
SE0001914D0 (sv) 2000-05-23
IE20000402A1 (en) 2001-01-10
DK200000792A (da) 2000-12-04
US6022539A (en) 2000-02-08
GB2352173B (en) 2004-11-10
DK177177B1 (da) 2012-04-30
NO20002686L (no) 2000-12-04
CA2308842A1 (en) 2000-12-03

Similar Documents

Publication Publication Date Title
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
NO20002686D0 (no) Forbedring av Peyronies sykdom
NO981388D0 (no) Bedring av Dupuytrens sykdom
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
DZ2495A1 (fr) Formule nouvelle de l'oméprazole-s.
NO953262D0 (no) Bedring av Dupuytrens sykdom
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
NO20010490D0 (no) Inhibisjon av ''graft-versus-host''-sykdom
FR2802852B3 (fr) Production d'elements figures
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
UA3394S (uk) Емблема "інтерфейс"
UA3396S (uk) Куртка дитяча
UA3541S (uk) Карамель "рокс"
UA3352S (uk) Торт "сердечко"
UA3553S (uk) Цитрусова карамель "рокс"
UA3874S (uk) Кепка жіноча
UA3730S (uk) Кепка жіноча
UA3732S (uk) Кепка жіноча
UA3603S (uk) Комплект етикеток "лонгер"
UA3711S (uk) Сувенір "святиня"
UA3495S (uk) Печиво "аладін"
UA3629S (uk) Декорація гри "телефортуна"
UA25492A (uk) Спосіб лікуваhhя хвороби гіршпруhга

Legal Events

Date Code Title Description
MK1K Patent expired